Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.

Bai B, Hales CM, Chen PC, Gozal Y, Dammer EB, Fritz JJ, Wang X, Xia Q, Duong DM, Street C, Cantero G, Cheng D, Jones DR, Wu Z, Li Y, Diner I, Heilman CJ, Rees HD, Wu H, Lin L, Szulwach KE, Gearing M, Mufson EJ, Bennett DA, Montine TJ, Seyfried NT, Wingo TS, Sun YE, Jin P, Hanfelt J, Willcock DM, Levey A, Lah JJ, Peng J.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16562-7. doi: 10.1073/pnas.1310249110. Epub 2013 Sep 10.

2.

Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain.

Pranski EL, Van Sanford CD, Dalal NV, Orr AL, Karmali D, Cooper DS, Costa N, Heilman CJ, Gearing M, Lah JJ, Levey AI, Betarbet RS.

Neurosci Lett. 2012 Jun 27;520(1):104-9. doi: 10.1016/j.neulet.2012.05.043. Epub 2012 May 23.

3.

Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration.

Gozal YM, Seyfried NT, Gearing M, Glass JD, Heilman CJ, Wuu J, Duong DM, Cheng D, Xia Q, Rees HD, Fritz JJ, Cooper DS, Peng J, Levey AI, Lah JJ.

Mol Neurodegener. 2011 Nov 29;6:82. doi: 10.1186/1750-1326-6-82.

4.

Differential effects of allosteric M(1) muscarinic acetylcholine receptor agonists on receptor activation, arrestin 3 recruitment, and receptor downregulation.

Davis AA, Heilman CJ, Brady AE, Miller NR, Fuerstenau-Sharp M, Hanson BJ, Lindsley CW, Conn PJ, Lah JJ, Levey AI.

ACS Chem Neurosci. 2010 Aug 18;1(8):542-551.

5.

[22q11 deletion syndrome].

Olesen C, Agergaard P, Boers M, Farholt S, Heilman CJ, Hvidkjaer L, Kristensen K, Lauritsen MB, Lunding J, Nielsen BW, Skovby F, Thrane N, Vogel I, Ƙstergaard JR.

Ugeskr Laeger. 2010 Mar 29;172(13):1038-46. Review. Danish.

PMID:
20350479
6.

SPE-39 family proteins interact with the HOPS complex and function in lysosomal delivery.

Zhu GD, Salazar G, Zlatic SA, Fiza B, Doucette MM, Heilman CJ, Levey AI, Faundez V, L'hernault SW.

Mol Biol Cell. 2009 Feb;20(4):1223-40. doi: 10.1091/mbc.E08-07-0728. Epub 2008 Dec 24.

7.

Production of antisera using fusion proteins.

Dodson SE, Heilman CJ, Kahn RA, Levey AI.

Curr Protoc Neurosci. 2007 Jul;Chapter 5:Unit 5.7. doi: 10.1002/0471142301.ns0507s40.

PMID:
18428660
8.

Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice.

Bazalakova MH, Wright J, Schneble EJ, McDonald MP, Heilman CJ, Levey AI, Blakely RD.

Genes Brain Behav. 2007 Jul;6(5):411-24. Epub 2006 Sep 8.

9.

Loss of apolipoprotein E receptor LR11 in Alzheimer disease.

Scherzer CR, Offe K, Gearing M, Rees HD, Fang G, Heilman CJ, Schaller C, Bujo H, Levey AI, Lah JJ.

Arch Neurol. 2004 Aug;61(8):1200-5. Erratum in: Arch Neurol. 2007 Apr;64(4):557.

PMID:
15313836
10.

Vesicular localization and activity-dependent trafficking of presynaptic choline transporters.

Ferguson SM, Savchenko V, Apparsundaram S, Zwick M, Wright J, Heilman CJ, Yi H, Levey AI, Blakely RD.

J Neurosci. 2003 Oct 29;23(30):9697-709.

11.

Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.

Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI.

J Comp Neurol. 1997 Nov 17;388(2):211-27.

PMID:
9368838
12.

Cloning and localization of exon 5-containing isoforms of the NMDAR1 subunit in human and rat brains.

Nash NR, Heilman CJ, Rees HD, Levey AI.

J Neurochem. 1997 Aug;69(2):485-93.

13.

Presenilin-1 protein expression in familial and sporadic Alzheimer's disease.

Levey AI, Heilman CJ, Lah JJ, Nash NR, Rees HD, Wakai M, Mirra SS, Rye DB, Nochlin D, Bird TD, Mufson EJ.

Ann Neurol. 1997 Jun;41(6):742-53.

PMID:
9189035
14.

Immunochemical analysis of dopamine transporter protein in Parkinson's disease.

Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey AI.

Ann Neurol. 1997 Apr;41(4):530-9.

PMID:
9124811
15.

Light and electron microscopic localization of presenilin-1 in primate brain.

Lah JJ, Heilman CJ, Nash NR, Rees HD, Yi H, Counts SE, Levey AI.

J Neurosci. 1997 Mar 15;17(6):1971-80.

16.

Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies.

Gutekunst CA, Levey AI, Heilman CJ, Whaley WL, Yi H, Nash NR, Rees HD, Madden JJ, Hersch SM.

Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8710-4.

17.

Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents.

Hersch SM, Ciliax BJ, Gutekunst CA, Rees HD, Heilman CJ, Yung KK, Bolam JP, Ince E, Yi H, Levey AI.

J Neurosci. 1995 Jul;15(7 Pt 2):5222-37.

18.

Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation.

Levey AI, Edmunds SM, Koliatsos V, Wiley RG, Heilman CJ.

J Neurosci. 1995 May;15(5 Pt 2):4077-92.

19.

Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the rat.

Levey AI, Edmunds SM, Hersch SM, Wiley RG, Heilman CJ.

J Comp Neurol. 1995 Jan 16;351(3):339-56.

PMID:
7706546
20.

Localization of muscarinic m3 receptor protein and M3 receptor binding in rat brain.

Levey AI, Edmunds SM, Heilman CJ, Desmond TJ, Frey KA.

Neuroscience. 1994 Nov;63(1):207-21.

21.
22.

Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells.

Jones SV, Heilman CJ, Brann MR.

Mol Pharmacol. 1991 Aug;40(2):242-7.

PMID:
1652053
23.

Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.

Isola VJ, Eisenberg RJ, Siebert GR, Heilman CJ, Wilcox WC, Cohen GH.

J Virol. 1989 May;63(5):2325-34.

24.

Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.

Torseth JW, Cohen GH, Eisenberg RJ, Berman PW, Lasky LA, Cerini CP, Heilman CJ, Kerwar S, Merigan TC.

J Virol. 1987 May;61(5):1532-9.

25.

Comparative study of flurbiprofen and morphine for postsurgical gynecologic pain.

Morrison JC, Harris J, Sherrill J, Heilman CJ, Bucovaz ET, Wiser WL.

Am J Med. 1986 Mar 24;80(3A):55-9.

PMID:
3515925
26.

Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge.

Eisenberg RJ, Cerini CP, Heilman CJ, Joseph AD, Dietzschold B, Golub E, Long D, Ponce de Leon M, Cohen GH.

J Virol. 1985 Dec;56(3):1014-7.

27.

Detection in antisera of antibodies that cross-react with herpes simplex virus type 1 glycoprotein gC.

Zweig M, Heilman CJ Jr, Bladen SV, Showalter SD, Hampar B.

Infect Immun. 1983 Aug;41(2):482-7.

28.

Herpes simplex virus type 2 glycoprotein gF and type 1 glycoprotein gC have related antigenic determinants.

Zweig M, Showalter SD, Bladen SV, Heilman CJ Jr, Hampar B.

J Virol. 1983 Jul;47(1):185-92.

30.
31.

Production of monoclonal antibodies against nucleocapsid proteins of herpes simplex virus types 1 and 2.

Zweig M, Heilman CJ Jr, Rabin H, Hopkins RF 3rd, Neubauer RH, Hampar B.

J Virol. 1979 Nov;32(2):676-8.

32.

Viral hepatitis associated with day-care centers.

Storch G, McFarland LM, Kelso K, Heilman CJ, Caraway CT.

JAMA. 1979 Oct 5;242(14):1514-8.

PMID:
470089
33.

Identification of disulfide-linked protein complexes in the nucleocapsids of herpes simplex virus type 2.

Zweig M, Heilman CJ Jr, Hampar B.

Virology. 1979 Apr 30;94(2):442-50. No abstract available.

PMID:
222065
35.

Spontaneous expression of endogenous type C RNA virus by BALB/c splenic B lymphocytes in continuous culture.

Premkumar-Reddy E, Price PJ, Heilman CJ, Sarma PS.

Virology. 1978 Feb;84(2):341-7. No abstract available.

PMID:
74896

Supplemental Content

Loading ...
Support Center